False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: The value of ultrasound in conjunction with preoperative lymphoscintigraphy

Melanoma Research

Volumn 19, Issue 2, 2009, Pages 94-99

  Lam, Tai K ^a   Uren, Roger F ^a,c   Scolyer, Richard A ^a,b,e   Quinn, Michael J ^a   Shannon, Kerwin F ^a,d   Thompson, John F ^a,f  

^a MELANOMA INSTITUTE AUSTRALIA   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c Suite 304   (Australia)

^d Disciplines of DSurgery ^*

^e Pathology Surgery

^f University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY; DIGOXIN; RADIOACTIVE MATERIAL; WARFARIN; COLORING AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM DERIVATIVE; TECHNETIUM TC 99M ANTIMONY SULFIDE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DRUG UPTAKE; ECHOGRAPHY; FALSE NEGATIVE RESULT; HEART ATRIUM FIBRILLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN-TRANSIT METASTASIS; LYMPH FLOW; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH OBSTRUCTION; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM DISEASE; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; NECK DISSECTION; NEEDLE BIOPSY; OSTEOARTHRITIS; PAROTIDECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SKIN ULCER; TOTAL HIP PROSTHESIS; TUMOR BIOPSY; AXILLA; FACE TUMOR; FLOW KINETICS; LABORATORY DIAGNOSIS; LYMPHADENECTOMY; METASTASIS; METHODOLOGY; MIDDLE AGED; PAROTID GLAND TUMOR; PATHOLOGY; SCINTISCANNING; SKIN TUMOR; TISSUE DISTRIBUTION;

AGED, 80 AND OVER; ANTIMONY; AXILLA; BIOPSY, FINE-NEEDLE; COLORING AGENTS; DIAGNOSTIC ERRORS; FACIAL NEOPLASMS; FALSE NEGATIVE REACTIONS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PAROTID NEOPLASMS; RADIOPHARMACEUTICALS; RHEOLOGY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION;

EID: 65449165022     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32832166b7     Document Type: Article

References (31)

1. Thompson JF, Shaw HM. Benefits of sentinel node biopsy for melanoma: a review based on interim results of the first multicenter selective lymphadenectomy trial. ANZ J Surg 2006; 76:100-103.
2. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355:1307-1317.
3. Thompson JF, Uren RF. What is a 'sentinel' lymph node? Eur J Surg Oncol 2000; 26:103-104.
4. Morton DL, Cagle L, Wong J, Economou JS, Foshag LJ, Wen DR, et al. Intraoperative lymphatic mapping and selective lymphadenectomy: technical details of a new procedure for clinical stage I melanoma. In Forty-Third Annual Cancer Symposium of the Society of Surgical Oncology. Washington, DC; 1990.
5. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220:759-767.
6. Thompson JF, McCarthy WH, Bosch CM, O'Brien CJ, Quinn MJ, Paramaesvaran S, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5:255-260.
7. Thompson JF, Uren RF, Shaw HM, McCarthy WH, Quinn MJ, O'Brien CJ, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 1999; 189:195-204.
8. Uren RF, Thompson JF, Howman-Giles R. Lymphatic drainage of the skin and breast: locating the sentinel lymph nodes. Amsterdam: Harwood Academic Publishers; 1999.
9. Thompson JF, Niewind P, Uren RF, Bosch CM, Howman-Giles R, Vrouenraets BC. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. Melanoma Res 1997; 7:500-506.
10. Cochran AJ, Wen DR, Herschman HR, Gaynor RB. Detection of S-100 protein as an aid to the identification of melanocytic tumours. Int J Cancer 1982; 30:295-297.
11. Ruiter DJ, Brocker EB. Immunohistochemistry in the evaluation of melanocytic tumours. Semin Diagn Pathol 1993; 10:76-91.
12. Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003; 238:538-549.
13. Takeuchi H, Morton DL, Kuo C, Turner RR, Elashoff D, Elashoff R, et al. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol 2004; 22:2671-2680.
14. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999; 230:453-463; discussion 463-465.
15. Jansen L, Nieweg OE, Peterse JL, Hoefnagel CA, Olmos RA, Kroon BB. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000; 87:484-489.
16. Clary BM, Mann B, Brady MS, Lewis JJ, Coit DG. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol 2001; 8:328-337.
17. Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C, Lee JJ, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16:2253-2260.
18. Gadd MA, Cosimi AB, Yu J, Duncan LM, Yu L, Flotte TJ, et al. Outcome of patients with melanoma and histologicalally negative sentinel lymph nodes. Arch Surg 1999; 134:381-387.
19. Harlow SP, Krag DN, Ashikaga T, Weaver DL, Meijer SJ, Loggie BW, et al. Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res 2001; 11:45-55.
20. Yee VS, Thompson JF, McKinnon JG, Scolyer RA, Li LX, McCarthy WH, et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 2005; 12:429-439.
21. Li LX, Scolyer RA, Ka VS, McKinnon JG, Shaw HM, McCarthy SW, et al. Pathological review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathological study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol 2003; 27 :1197-1202.
22. Scolyer RA, Thompson JF, Li LX, Beavis A, Dawson M, Doble P, et al. Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: evidence from antimony concentrations in false-negative sentinel nodes from melanoma patients. Ann Surg Oncol 2004; 11:174S-178S.
23. Scolyer RA, Thompson JF, Li LX, Beavis A, Dawson M, Doble P, et al. Antimony concentrations in nodal tissue can confirm sentinel node identity. Mod Pathol 2004; 17:1191-1197.
24. Uren RF, Howman-Giles R, Chung DK, Thompson JF. Metastatic occlusion of a lymphatic collecting vessel in a patient with cutaneous melanoma and clinically normal lymph nodes. Clin Nucl Med 2007; 32:312-313.
25. Estourgie SH, Nieweg OE, Valdes Olmos RA, Rutgers EJ, Peterse JL, Kroon BB. Eight false negative sentinel node procedures in breast cancer: what went wrong? Eur J Surg Oncol 2003; 29:336-340.
26. Thompson JF, Uren RF, Saw RP, Stevens GN. Internal mammary node metastasis from primary cutaneous melanoma on the anterior chest. ANZ J Surg 2005; 75:723-725.
27. Uren RF, Howman-Giles RB, Thompson JF, Shaw HM, McCarthy WH. Lymphatic drainage from peri-umbilical skin to internal mammary nodes. Clin Nucl Med 1995; 20:254-255.
28. Uren RF, Howman-Giles R, Thompson JF, Quinn MJ, O'Brien C, Shaw HM, et al. Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back. J Nucl Med 1996; 37:964-966.
29. Uren RF, Howman-Giles R, Thompson JF, McCarthy WH. Exclusive lymphatic drainage from a melanoma on the back to intraabdominal lymph nodes. Clin Nucl Med 1998; 23:71-73.
30. Uren RF, Howman-Giles R, Thompson JF, Shaw HM, Roberts JM, Bernard E, et al. High-resolution ultrasound to diagnose melanoma metastases in patients with clinically palpable lymph nodes. Australas Radiol 1999; 43 :148-152.
31. Starritt EC, Uren RF, Scolyer RA, Quinn MJ, Thompson JF. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol 2005; 12:18-23.